Article Details

Abivax Suspends Trading of its Shares Until the Publication of ABX464 Phase 2b Results in ...

Retrieved on: 2021-05-24 08:15:00

Tags for this article:

Click the tags to see associated articles and topics

Abivax Suspends Trading of its Shares Until the Publication of ABX464 Phase 2b Results in .... View article details on hiswai:

Excerpt

Abivax, a clinical stage biotechnology company, is developing novel therapies that modulate the body's natural immune machinery to treat patients ...

Article found on: www.benzinga.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up